Bisphosphonate-associated atypical femoral fractures and one-year mortality.
作者信息
Kharazmi Mohammad, Hallberg Pär
机构信息
Central Hospital, Department of Oral and Maxillofacial Surgery , Västerås , Sweden.
出版信息
Ups J Med Sci. 2014 Nov;119(4):357-8. doi: 10.3109/03009734.2014.959213. Epub 2014 Sep 18.
Abstract
摘要
相似文献
1
Bisphosphonate-associated atypical femoral fractures and one-year mortality.
Ups J Med Sci. 2014 Nov;119(4):357-8. doi: 10.3109/03009734.2014.959213. Epub 2014 Sep 18.
2
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.
J Bone Joint Surg Am. 2013 Feb 20;95(4):297-307. doi: 10.2106/JBJS.K.01181.
3
A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture.
Calcif Tissue Int. 2019 Jul;105(1):51-67. doi: 10.1007/s00223-019-00546-9. Epub 2019 Apr 20.
4
Mortality After Atypical Femoral Fractures: A Cohort Study.
J Bone Miner Res. 2016 Mar;31(3):491-7. doi: 10.1002/jbmr.2767. Epub 2016 Jan 8.
5
Bilateral atypical femur fractures without bisphosphonate exposure.
Skeletal Radiol. 2017 Feb;46(2):241-247. doi: 10.1007/s00256-016-2526-0. Epub 2016 Nov 30.
6
Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication.
Cleve Clin J Med. 2018 Nov;85(11):885-893. doi: 10.3949/ccjm.85a.17119.
7
Bisphosphonate-associated atypical subtrochanteric femur fracture.
J Nucl Med Technol. 2015 Mar;43(1):72-3. doi: 10.2967/jnmt.114.139923. Epub 2014 Aug 14.
8
Bisphosphonate use and atypical fractures of the femoral shaft.
N Engl J Med. 2011 May 5;364(18):1728-37. doi: 10.1056/NEJMoa1010650.
9
What do we know about atypical femoral fractures? Insights and enigmas.
Joint Bone Spine. 2011 Dec;78(6):568-71. doi: 10.1016/j.jbspin.2011.03.015. Epub 2011 May 17.
10
Atypical femoral fractures and bisphosphonate use.
N Engl J Med. 2010 May 13;362(19):1848-9. doi: 10.1056/NEJMc0910389.
引用本文的文献
1
Efficacy of autologous bone marrow derived Mesenchymal stem cells (MSCs), osteoblasts and osteoblasts derived exosome in the reversal of ovariectomy (OVX) induced osteoporosis in rabbit model.
Am J Transl Res. 2021 Jun 15;13(6):6175-6181. eCollection 2021.
2
Stem-cell therapy for ovariectomy-induced osteoporosis in rats: a comparison of three treatment modalities.
Stem Cells Cloning. 2019 Jun 14;12:17-25. doi: 10.2147/SCCAA.S204099. eCollection 2019.
3
Bone Marrow-derived Osteoblasts in the Management of Ovariectomy induced Osteoporosis in Rats.
J Stem Cells Regen Med. 2018 Dec 30;14(2):63-68. doi: 10.46582/jsrm.1402010. eCollection 2018.
本文引用的文献
1
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
J Bone Miner Res. 2014 Jan;29(1):1-23. doi: 10.1002/jbmr.1998. Epub 2013 Oct 1.
2
Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study.
BMC Musculoskelet Disord. 2011 May 20;12:105. doi: 10.1186/1471-2474-12-105.
3
Survival after hip fracture.
Osteoporos Int. 2005 Dec;16(12):1583-90. doi: 10.1007/s00198-005-2024-z. Epub 2005 Oct 11.
4
Severely suppressed bone turnover: a potential complication of alendronate therapy.
J Clin Endocrinol Metab. 2005 Mar;90(3):1294-301. doi: 10.1210/jc.2004-0952. Epub 2004 Dec 14.
5
Population-based study of survival after osteoporotic fractures.
Am J Epidemiol. 1993 May 1;137(9):1001-5. doi: 10.1093/oxfordjournals.aje.a116756.
Zotero 插件